financetom
Business
financetom
/
Business
/
Informa agrees $1.6 billion deal for Cannes Lions owner Ascential
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Informa agrees $1.6 billion deal for Cannes Lions owner Ascential
Jul 23, 2024 11:52 PM

LONDON, July 24 (Reuters) - Britain's Informa ( IFPJF )

said on Wednesday it had agreed to buy Cannes Lions Festival

owner Ascential ( AIAPF ) for 1.2 billion pounds ($1.6 billion),

adding the prominent advertising industry conference to its

portfolio of events.

Ascential ( AIAPF ), which also owns the Money20/20 fintech events,

said on Tuesday after the market closed that it had received the

cash offer, which it was minded to recommend.

Informa ( IFPJF ) said it would expand both events into more sectors

and accelerate growth, helped by its first-party data platform

and understanding of both the marketing and fintech sectors.

It has agreed to pay 568 pence per share, representing a 53%

premium on the closing price of 371 pence on Monday.

Informa ( IFPJF ) announced the deal alongside its first-half results

that showed underlying operating profit growth of 18.8% and

revenue growth of 11%.

The strong performance enabled it to upgrade its

expectations for the full year.

It said adjusted operating profit would be above the top of

current guidance, which stands at 970 million pounds, and now

could be up to 1 billion pounds.

($1 = 0.7756 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved